一个药物诱导的胰腺炎病例
Muskan Shrestha1, Pratick Shrestha2, Adarsha Mahaseth3
1Manmohan Cardiothoracic Vascular and Transplant Center Kathmandu Nepal.
Clinical case reports
|January 26, 2026
概括
抗生素西普罗夫洛克萨很少会导致药物诱导胰腺炎 (DIP),这是一个严重的疾病. 迅速停止使用药物并提供支持性护理,导致患有这种罕见不良反应的患者迅速康复.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 药物诱导性胰腺炎 (DIP) 是一种罕见但重要的急性腹痛原因.
- 与诺基诺隆抗生素西普罗夫洛克萨相关的DIP病例非常罕见.
研究的目的:
- 报告一种罕见的药物诱导性胰腺炎 (DIP) 病例,该病例是由西普洛素引起的.
- 强调在诺基诺治疗期间患有腹部疼痛的患者考虑DIP的重要性.
主要方法:
- 一个35岁妇女的病例报告显示,她患有急性胃上部疼痛.
- 诊断工作包括实验室测试 (氨酶,脂酶) 和对比度增强CT.
- 排除常见的胰腺炎病因 (胆结石,酒精等). ) 的情况.
- 使用纳兰乔尺度和巴达洛夫分类来评估因果关系.
主要成果:
- 患者在自行处方西普罗夫洛克萨治疗腹3天后出现严重的胰腺炎.
- 血清粉酶和脂酶水平升高,CT证实急性间歇性胰腺炎.
- 排除了常见的病因,并确定了西普罗夫洛克萨作为可能的致病原体.
- 停止使用西普罗夫洛克萨和支持性护理导致在4天内迅速的临床和生化改善.
结论:
- 齐普罗夫洛克萨可能是药物诱导胰腺炎的罕见原因.
- 早期识别和戒断违规药物对于有利的结果至关重要.
- 这一案例强调了在诺基诺治疗期间患有急性腹痛的患者需要考虑DIP的必要性.
相关概念视频
Pancreatic Juice and Secretion
2.9K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
2.9K
Acute Pancreatitis I: Introduction
1.2K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Chronic Pancreatitis I: Introduction
725
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
725
Chronic Pancreatitis II: Collaborative Care
349
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
349
Pharmacokinetics: Drug–Drug Interactions
428
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
428
Bioequivalence of Drugs: Drugs with Multiple Indications
156
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
156


